Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

M-100907 improves positive and negative symptoms and is well tolerated in schizophrenics

July 15, 1998

Preliminary evidence of antidepressant effect for igmesine, a sigma ligand

July 15, 1998

Mitsui Toatsu describes potent, long-acting and orally bioavailable antipsychotic agents

July 15, 1998

CR-2945, a promising new anxiolytic agent in preclinical testing

July 15, 1998

World's first brain cell transplant performed in stroke patient

July 15, 1998

Centrally acting muscarinic agents discovered at American Home Products

July 15, 1998

Neurocrine Biosciences takes over clinical development of benzodiazepine

July 15, 1998

FDA requests additional analysis of Exelon before U.S. approval

July 15, 1998

Antipsychotic drug trifluoperazine inhibits growth of mycobacterial isolates

July 15, 1998

Merck & Co.'s new tachykinin antagonists

July 14, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...